The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Jan 8

PMID 39766110

Authors

Sandra Solares

Javier Leon

Lucia Garcia-Gutierrez

Affiliations

Soon will be listed here.

Abstract

The Epstein-Barr virus (EBV) is associated with a wide range of diseases, malignant and non-malignant. EBV was, in fact, the first virus described with cell transformation capacity, discovered by Epstein in 1964 in lymphoma samples from African children. Since then, EBV has been associated with several human tumors including nasopharyngeal carcinoma, gastric carcinoma, T-cell lymphoma, Hodgkin lymphoma, diffuse large B cell lymphoma, and Burkitt lymphoma among others. The molecular hallmark of Burkitt lymphoma (BL) is a chromosomal translocation that involves the gene and immunoglobulin loci, resulting in the deregulated expression of , an oncogenic transcription factor that appears deregulated in about half of human tumors. The role of MYC in lymphoma is well established, as MYC overexpression drives B cell proliferation through multiple mechanisms, foremost, the stimulation of the cell cycle. Indeed, MYC is found overexpressed or deregulated in several non-Hodgkin lymphomas. Most endemic and many sporadic BLs are associated with EBV infection. While some mechanisms by which EBV can contribute to BL have been reported, the mechanism that links translocation and EBV infection in BL is still under debate. Here, we review the main EBV-associated diseases, with a special focus on BL, and we discuss the interaction of EBV and translocation during B cell malignant transformation in BL.

References

Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W . c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell. 2012; 151(1):68-79. PMC: 3471363. DOI: 10.1016/j.cell.2012.08.033. View

Roudier J, Petersen J, Rhodes G, Luka J, Carson D . Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A. 1989; 86(13):5104-8. PMC: 297565. DOI: 10.1073/pnas.86.13.5104. View

Ruf I, Rhyne P, Yang H, Borza C, Hutt-Fletcher L, Cleveland J . EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Curr Top Microbiol Immunol. 2001; 258:153-60. DOI: 10.1007/978-3-642-56515-1_10. View

Dunmire S, Grimm J, Schmeling D, Balfour Jr H, Hogquist K . The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events. PLoS Pathog. 2015; 11(12):e1005286. PMC: 4666617. DOI: 10.1371/journal.ppat.1005286. View

Kintner C, Sugden B . The structure of the termini of the DNA of Epstein-Barr virus. Cell. 1979; 17(3):661-71. DOI: 10.1016/0092-8674(79)90273-3. View

Lombardi L, Newcomb E, Dalla-Favera R . Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell. 1987; 49(2):161-70. DOI: 10.1016/0092-8674(87)90556-3. View

Coller H, Grandori C, Tamayo P, Colbert T, Lander E, Eisenman R . Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A. 2000; 97(7):3260-5. PMC: 16226. DOI: 10.1073/pnas.97.7.3260. View

Mouhieddine T, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury S . Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. Clin Immunol. 2015; 158(1):59-66. DOI: 10.1016/j.clim.2015.03.011. View

Adamson A, Kenney S . Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology. 1998; 251(1):187-97. DOI: 10.1006/viro.1998.9396. View

10.

Biggin M, Bodescot M, Perricaudet M, Farrell P . Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol. 1987; 61(10):3120-32. PMC: 255889. DOI: 10.1128/JVI.61.10.3120-3132.1987. View

11.

Carbajal K, Mironova Y, Ulrich-Lewis J, Kulkarni D, Grifka-Walk H, Huber A . Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. J Immunol. 2015; 195(6):2552-9. PMC: 4561206. DOI: 10.4049/jimmunol.1501097. View

12.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748. PMC: 9214472. DOI: 10.1038/s41375-022-01620-2. View

13.

Wang R, Wang J, Zhang N, Wan Y, Liu Y, Zhang L . The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim. Biochem Biophys Res Commun. 2019; 511(4):787-793. DOI: 10.1016/j.bbrc.2019.02.108. View

14.

Sun K, Jia K, Lv H, Wang S, Wu Y, Lei H . EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives. Front Oncol. 2020; 10:583463. PMC: 7769310. DOI: 10.3389/fonc.2020.583463. View

15.

Guikema J, Schuuring E, Kluin P . Structure and consequences of IGH switch breakpoints in Burkitt lymphoma. J Natl Cancer Inst Monogr. 2008; (39):32-6. DOI: 10.1093/jncimonographs/lgn020. View

16.

Kalchschmidt J, Bashford-Rogers R, Paschos K, Gillman A, Styles C, Kellam P . Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells. J Exp Med. 2016; 213(6):921-8. PMC: 4886369. DOI: 10.1084/jem.20160120. View

17.

Coleman C, Wohlford E, Smith N, King C, Ritchie J, Baresel P . Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol. 2014; 89(4):2301-12. PMC: 4338898. DOI: 10.1128/JVI.03001-14. View

18.

Murray P, Young L . An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma. Blood. 2019; 134(7):591-596. DOI: 10.1182/blood.2019000568. View

19.

Lunemann J, Jelcic I, Roberts S, Lutterotti A, Tackenberg B, Martin R . EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med. 2008; 205(8):1763-73. PMC: 2525578. DOI: 10.1084/jem.20072397. View

20.

Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C . Epstein-Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases. Int J Mol Sci. 2024; 25(15). PMC: 11311853. DOI: 10.3390/ijms25158160. View